Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Wednesday, August 26, 2026

Snapshot: Aug 26, 2026 · 6:00 PM 100 stocks analyzed

Down Day

Wed, Aug 26, 2026 Broad Selloff High

Broad selloff crushed Russell 2000 by 0.89% as tech stumbled, but high dispersion created a stock-picker's paradise with nearly two dozen news-driven gainers offsetting sector l…

55% Market-wide selloff dominated the day: S&P 500 fell 0.42%, NASDAQ composite dropped 0.76%, and small caps were hammered hardest with Russell 2000 down 0.89%, signaling broad risk-off sentiment despite VIX ticking down 5%. Losses concentrated in Technology (21.6% of losers) and Healthcare (18.9% of losers), though the latter also produced the most gainers.
30% Extreme dispersion and earnings-driven rallies created sharp stock-picker opportunities: 50 gainers averaged +24% with news-grounded winners including Mercer (+70.7% on Canadian mill subsidy), Reading International (+55.9% on earnings beat), Okta (+24.1%), Salesforce (+14.1%), and CrowdStrike (+14.3%), while Healthcare captured 34% of gainers despite sector weakness, suggesting selective strength within beaten-down names.
15% Catastrophic losses in micro-cap names dominated the losers' list with ONTX collapsing 96.5%, SVVC dropping 62%, and multiple sub-$20 stocks experiencing 30-40% declines, reflecting technical liquidation and undisclosed catalysts typical of high-dispersion selloff days; reverse-stock-split announcements (Cycurion, Veea) and dilutive offerings (Greenland Mines at 48.5% discount) added to forced selling pressure.

Healthcare drove 34% of gainers 5 names returned after long absences XPON · 3-day gainers streak FBDT · 3-day losers streak WNW — first appearance ANF — first appearance

Market Regime

Wed, Aug 26, 2026 Risk-On conf: medium macro · prototype

+30

Tailwind −100 … +100 · + tailwind / − headwind

VIX15.2 p12 Drawdown-1.6% Held2d · nascent SinceAug 25

Top drivers: VIX percentile ▲ S&P 20d return ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Wed, Aug 26, 2026 13

S&P 500

7,675.70

−32.28

-0.42%

Dow Jones

53,463.88

+0.83

+0.00%

NASDAQ Composite

26,130.20

−200.89

-0.76%

NASDAQ 100

29,224.52

−201.50

-0.68%

DJ US Total Market

76,024.37

−356.62

-0.47%

Russell 1000

4,185.61

−17.80

-0.42%

S&P MidCap 400

3,822.79

−21.20

-0.55%

Russell 2000

3,005.90

−27.04

-0.89%

Russell 2500

1,284.97

+1.47

+0.11%

Russell 3000

4,369.98

−19.46

-0.44%

Nasdaq Financial-100

7,790.23

−22.33

-0.29%

NIFTY 50

24,207.75

−24.10

-0.10%

VIX

15.21

−0.80

-5.00%

Biggest Gainers

Wed, Aug 26, 2026 50

ZVZZT

$25.09+$11.04

+78.5%

MERC

Mercer International IncBasic Materials

$0.41+$0.31

+70.7%

NASDAQ · Mkt cap $31 M

Mercer International announced C$20 million (approximately US$14 million) in Canadian government support for its Peace River Mill on August 26, 2026, the same day the stock surged 70.7% to rank as the second-biggest gainer on the market.

The timing alignment between the government funding announcement and the massive single-day gain strongly suggests the news drove the move. The company received federal support through Prairies Economic Development Canada (PrairiesCan) to advance innovation and competitiveness at its Northern Alberta forest facility. For a small-cap forest products company, a C$20 million capital injection represents meaningful financial relief and signals government confidence in the operation's viability. This type of support can improve cash flow, reduce operational strain, or enable strategic investments that boost investor confidence. The stock's exceptionally strong reaction suggests investors viewed this as materially positive, either reducing financial distress concerns or validating the company's operational prospects. The coincidence of the media advisory timeline and formal announcement on the same day supports news as the primary catalyst.

RDIB

Reading International IncCommunication Services

$15.47+$5.37

+55.9%

NASDAQ · Mkt cap $204 M

Reading International posted record Q2 2026 Australian revenue and a 159% surge in global operating income, which likely drove the 55.94% jump as investors responded positively to the earnings beat and improved operational performance.

The earnings call highlights released on 2026-08-26 provide clear evidence of a substantial operational turnaround. Record Australian revenue combined with a 159% year-over-year surge in global operating income represents meaningful improvement in the company's core cinema operations. This is particularly notable given that Reading International had faced challenges with debt refinancing and liquidity pressures, both of which management addressed in the call. The magnitude of the stock move—ranking third among daily gainers—aligns with the scale of the earnings beat. While the headlines also mention ongoing debt refinancing and asset sales (which are somewhat concerning from a leverage standpoint), the market appears to have weighted the strong operational results more heavily than the capital structure challenges, treating them as manageable rather than existential. This suggests investor sentiment shifted from distress to recovery expectations.

WNW

Wunong Net Technology Company Limited

$2.45+$1.24

+49.6%

VNRX

VolitionRX LtdHealthcare

$0.33+$0.16

+40.9%

NYSE · Mkt cap $6.5 M

VolitionRx announced landmark clinical validation of its Nu.Q NETs biomarker in sepsis and highlighted broad commercial momentum across multi-billion dollar markets, triggering a 41% single-day surge in the micro-cap biotech stock.

On 2026-08-26, VolitionRx released two coordinated announcements: publication of peer-reviewed clinical validation for its Nu.Q NETs H3.1 biomarker in sepsis treatment, and a broader corporate update emphasizing commercial progress across $27+ billion addressable markets. For a micro-cap diagnostic biotech company trading at $0.33, clinical validation papers and evidence of commercial momentum are material catalysts. The stock's position as the fifth-largest daily gainer suggests the market viewed these developments as meaningful de-risking of the company's pipeline and commercial execution. The timing and coordination of announcements indicates planned disclosure rather than market reaction to leaked information. No contradictory news or clinical setbacks are evident in the provided headlines.

MIMI

Mint Incorporation LimitedIndustrials

$1.79+$0.73

+38.4%

NASDAQ · Mkt cap $14 M

Mint Incorporation announced a strategic robotics expansion partnership with Yunji Technology to develop next-generation commercial-grade service robots, driving a 38% gain as the market responded positively to the growth initiative.

The headline from August 26 at 12:30 UTC describes Mint accelerating its robotics expansion through a strategic partnership with Yunji Technology focused on developing next-generation commercial-grade service robots. This announcement directly preceded the stock's 38% intraday jump to $1.79, making it the sixth-largest gainer on the day. The timing alignment is strong. The partnership appears to position Mint in the high-growth commercial robotics sector, which has attracted significant investor interest. The press release indicates this is a strategic development initiative rather than a completed product, so the market is pricing in future revenue potential. For a micro-cap or lower-priced stock like MIMI, robotics expansion announcements often trigger outsized enthusiasm, particularly when paired with named technology partnerships that suggest credibility and execution capability.

ANF

Abercrombie & Fitch CoConsumer Cyclical

$147.71+$39.90

+36.9%

NYSE · Mkt cap $6.7 B

Abercrombie & Fitch surged 36.91% on August 26 after reporting Q2 earnings that beat Wall Street expectations, posting record net sales of $1.27 billion with its 15th consecutive quarter of growth, and substantially raising full-year guidance.

The headline consensus is unambiguous: ANF delivered a strong earnings surprise on the top line, demonstrated sustained sales momentum across 15 consecutive quarters of growth, and provided an optimistic forward outlook that prompted investors to re-rate the stock higher. Multiple sources confirm the company beat profit expectations and raised full-year earnings guidance, with some reporting record Q2 net sales and increased share buyback targets. The timing on August 26 shows the earnings release triggered the majority of the move in the afternoon session. The broader consumer sector was mixed that day (some retailers softer late afternoon, but economic data showed resilient consumer spending), yet ANF's outperformance is fully explained by its own company-specific results rather than sector tailwinds. This is a textbook earnings-driven rally in a retail stock that has demonstrated consistent execution.

SOAR

Volato Group, Inc.Industrials

$0.25+$0.06

+36.7%

NYSE · Mkt cap $7.8 M

Volato Group announced a definitive merger agreement with Alignment Engine valued at $500 million in AI infrastructure, which likely drove the 36.74% intraday gain as the market priced in the strategic combination and growth potential.

On August 26, Volato Group released a major announcement of a definitive merger agreement with Alignment Engine, an AI infrastructure company, with an implied transaction value of $500 million. For a stock trading at $0.25, this represents a significant corporate development that offers shareholders exposure to the AI infrastructure sector and suggests management believes the combined entity has substantial value creation potential. The market's rapid response—ranking it the eighth largest gainer of the day—reflects typical investor enthusiasm for M&A announcements in high-growth sectors like AI. The headline does not provide deal terms, financing details, or timing, so the full economics remain partially opaque, but the sheer scale of a half-billion-dollar transaction is newsworthy for a stock at this price level.

ALPS

Alpine Summit Energy Partners, Inc.

$0.42+$0.11

+34.3%

NASDAQ · Mkt cap $55 M

No news headlines were found in the last 48 hours, so the cause of the 34% gain cannot be directly attributed to a named catalyst; the move may reflect technical recovery, a delayed market reaction, or sector-specific momentum in energy partnerships.

Alpine Summit Energy Partners is a master limited partnership (MLP) focused on energy infrastructure, a sector sensitive to commodity prices, interest rate expectations, and distributions. The complete absence of news in the 48-hour window before this significant jump suggests the driver was not a company-specific announcement, earnings release, or regulatory action. In MLPs and small-cap energy stocks, large single-day moves without concurrent news often reflect technical factors such as short covering, options-driven gamma effects, or delayed market digestion of prior week developments. Alternatively, the move could stem from a broader sector rally in energy or midstream equities driven by crude oil or natural gas price movements, or from a rumor not yet reflected in mainstream financial headlines. Without access to the broader market context or intraday trading data, pinpointing the precise catalyst remains speculative.

NOEMR

CO2 Energy Transition Corp. Right

$0.20+$0.05

+33.3%

NASDAQ

No news headlines were found in the last 48 hours, so the +33% gain on NOEMR likely reflects technical trading, retail interest in the energy transition sector, or a delayed market reaction to unreported developments.

The absence of recent news makes it difficult to pinpoint a specific catalyst for the 33% single-day jump. NOEMR is a right offering vehicle (a warrant or right tied to CO2 Energy Transition Corp), which means its price behavior can be sensitive to underlying SPAC or parent company developments, derivative positioning, or technical breakouts in thinly traded microcap securities. Energy transition stocks in August 2026 may have benefited from sector-wide momentum, policy announcements at the macro level that aren't yet reflected in individual stock headlines, or accumulation by algorithmic or retail traders. The ranking as the 10 biggest gainer suggests broad market awareness, but without accompanying headlines, the specific trigger remains opaque. It is also possible that material news exists but has not yet propagated to the RSS feed monitored.

XPON

Expion360 Inc.Industrials

$9.11+$2.11

+32.1%

NASDAQ · Mkt cap $3.6 M

No headlines were found in the last 48 hours, so the 32% jump cannot be attributed to public news. The move was likely driven by technical factors, a delayed announcement, or market rumors in a micro-cap security with potentially thin liquidity.

Expion360 is a small-cap battery and power solutions company, and the complete absence of recent headlines despite a top-11 daily move is notable. In thinly traded securities, large percentage moves can occur from modest absolute volume changes, technical breakouts, or short covering. Without access to pre-market news, after-hours announcements, or social media-driven retail attention, the specific catalyst remains obscured. Possibilities include a contract win or partnership announcement that bypassed major financial newswires, a technical breakdown of a resistance level triggering momentum buying, or accumulation by a larger holder. Given Expion360's sector focus on portable power systems, earnings surprises or deployment announcements at key customer accounts would be typical catalysts, but none are evident in the provided data.

WSHP

WeShop Holdings Limited Class A Ordinary SharesCommunication Services

$6.15+$1.44

+30.6%

NASDAQ · Mkt cap $118 M

WeShop released first half 2026 financial results on August 24, likely triggering the 30.64% gain on August 26 after investors reviewed the earnings announcement posted to the company website.

The only headline provided is a press release dated August 24 announcing that WeShop had posted its first half 2026 financial results on its investor relations website. The actual earnings figures, performance metrics, guidance commentary, or any specific financial achievements are not disclosed in the headline summary itself. The two-day lag between the announcement and the peak price move is consistent with time needed for market participants to access the full earnings release, digest results, and adjust positions. Without access to the actual earnings content—revenue growth, profitability, margin trends, or management commentary—we cannot identify what specific metrics or forward-looking statements drove the positive reaction. The 30.64% jump suggests market sentiment was constructive, but attribution to particular business fundamentals remains inference rather than fact.

BMGL

Basel Medical Group Ltd Ordinary SharesHealthcare

$5.93+$1.35

+29.3%

NASDAQ · Mkt cap $8.1 M

No news headlines were found in the last 48 hours, so the 29% gain likely reflects a delayed market reaction to an earlier announcement, technical trading, or undisclosed company developments not yet indexed by Yahoo Finance.

Basel Medical Group jumped 29% on August 26 without any corresponding news in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect suggests several possibilities. First, a material announcement may have been issued before the 48-hour window or may not yet be indexed in the news feed despite market reaction. Second, the move could reflect short covering or technical momentum in a lower-volume healthcare stock. Third, BMGL may have announced clinical trial results, regulatory progress, partnership news, or guidance that markets reacted to but which has not yet propagated through major financial news aggregators. Without access to the company's investor relations channels or broader news sources, the specific trigger cannot be confirmed from the evidence at hand.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.07+$0.02

+28.3%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours, so the 28% gain in HEPA stock cannot be attributed to a specific announced catalyst; the move likely reflects technical trading, short-covering, or delayed market reaction to earlier news.

The absence of any Yahoo Finance headlines in the last 48 hours surrounding this 28% jump is notable. For a micro-cap biotech stock trading at $0.07, moves of this magnitude are not uncommon and often occur without accompanying major news coverage. Possible explanations include: (1) technical rebound after oversold conditions or short-covering activity, both typical for illiquid penny stocks; (2) delayed market pricing of news released more than 48 hours ago that the RSS feed does not capture; (3) pre-clinical or clinical trial data that has not yet been formally reported through major news channels; (4) insider or sector-specific developments not yet broadly distributed. Without substantive news, we cannot determine which of these applies here.

BEEM

Beam GlobalTechnology

$1.73+$0.37

+27.8%

NASDAQ · Mkt cap $27 M

Beam Global reported strong Q2 2026 earnings with 174% sequential revenue surge and 21% year-over-year growth, plus expansion into European and defense markets, driving a 27.8% single-day rally.

The earnings call highlights released on August 25 establish concrete positive catalysts: sequential revenue jumped 174%, year-over-year growth reached 21%, and the company explicitly expanded into European and defense markets while maintaining a robust balance sheet positioned for large future orders. For a small-cap stock like BEEM trading at $1.73, beats of this magnitude on both sequential and YoY metrics combined with geographic and market expansion represent material operational progress. The earnings headline appears directly timed to the 27.8% move, suggesting investors reassessed the company's growth trajectory and order pipeline strength on hard financial results rather than speculation.

RDGT

Ridgetech IncHealthcare

$1.03+$0.21

+25.5%

NASDAQ · Mkt cap $2.9 M

No news headlines were found in the last 48 hours, so the 25.49% gain on RDGT likely stems from technical trading, a delayed announcement, or market rumors rather than a confirmed corporate event.

The absence of any news in the Yahoo Finance RSS feed over the past two days is notable given the stock's strong 16th-place ranking among daily gainers. For a micro-cap stock trading at $1.03, typical catalysts that drive 25% single-day moves include short covering or a squeeze on tight float, positive clinical or regulatory developments in biotech or healthcare plays, insider buying or activist involvement, or delayed material announcements that the market eventually learns about through other channels. Without confirmed headlines, the move appears driven by price action and market sentiment rather than disclosed corporate news. Ridgetech's low stock price and strong gain position it as the type of security that can move sharply on technical factors, retail momentum, or unconfirmed market chatter.

CJJD

China Jo-Jo Drugstores Inc

$1.03+$0.21

+25.1%

GPACW

Global Partner Acquisition Corp II

$0.30+$0.06

+24.9%

OKTA

Okta IncTechnology

$134.87+$31.43

+24.1%

NASDAQ · Mkt cap $36 B

Okta reported Q2 earnings and revenue that beat estimates with sales up 10.6% year-over-year to $805 million, while providing forward guidance above consensus expectations, driving the +24% surge.

The headlines establish that Okta delivered a clear earnings beat on August 26, 2026, with top-line revenue exceeding Wall Street estimates and forward guidance coming in above consensus. The company reported Q2 sales of $805 million, representing 10.6% year-over-year growth. Multiple sources confirm the stock jumped approximately 16.3% immediately following the earnings release, with the additional gains bringing it to +24.13% by market close. This move fits the pattern of strong cybersecurity earnings performance during the quarter, as peers like CrowdStrike also posted significant gains. The upside guidance appears to have been a key driver, signaling management confidence in the business trajectory and providing a positive narrative for the remainder of 2026.

RBOT

D8 Holdings Corp.Healthcare

$0.04+$0.01

+21.2%

NYSE · Mkt cap $257 K

No news headlines were found in the last 48 hours, so the 21% gain in RBOT appears driven by factors outside traditional news flow, likely technical or speculative momentum in a highly illiquid micro-cap stock trading at $0.04.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to point to a specific catalyst. RBOT is trading at an extremely low price point, which typically indicates either a distressed company, a shell, or a heavily diluted equity structure. Stocks at this price tier often experience outsized percentage moves on minimal volume due to thin liquidity and high susceptibility to retail speculation, short-covering squeezes, or coordinated social media interest. Without headline evidence, the jump is most likely attributable to technical factors such as oversold conditions triggering algorithmic buying, a short squeeze, or simply retail enthusiasm for a micro-cap stock that requires verification against company filings and current business status.

GTN.A

Gray Television Inc

$7.01+$1.22

+21.1%

LGCL

Lucas GC LimitedTechnology

$0.06+$0.01

+20.8%

NASDAQ · Mkt cap $10 M

No news was reported in the last 48 hours for LGCL, so the 20.81% gain on August 26 cannot be attributed to a documented headline catalyst. The move likely reflects technical trading, retail speculation, or an undisclosed news event.

The absence of any headline coverage in Yahoo Finance's RSS feed over the past 48 hours means we cannot tie this stock's jump to an earnings report, regulatory action, partnership announcement, or guidance change. LGCL is trading at $0.06, which suggests it is a micro-cap or penny stock where price movements can be volatile and driven by factors other than fundamental news, such as short covering, options expiration effects, retail trading volume spikes, or social media-driven momentum. Without documented catalyst information, the most plausible categories are technical bounce-back from an oversold condition, algorithmic or manual accumulation by retail traders, or a delayed market reaction to news not yet indexed by major financial RSS feeds.

MWYN

Marwynn Holdings, Inc. Common stockConsumer Cyclical

$1.30+$0.22

+19.6%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours for MWYN, so the 19.6% surge on August 26 cannot be attributed to a confirmed company announcement or public event disclosed through major financial media.

The absence of recent news makes it impossible to identify a specific catalyst from the headline record. A near-20% single-day jump in a stock trading at $1.30 on a major exchange typically reflects one or more of the following: a short squeeze or technical bounce (especially common in lower-priced equities with high short interest), delayed disclosure of material news not yet widely indexed by major news feeds, insider activity or rumors circulating on social media or trading forums, sector-wide momentum, options expiration dynamics, or a reversal after a prolonged decline. Without access to press releases, SEC filings, social media chatter, options data, or short interest metrics, it is not possible to determine which of these factors drove the move.

GAUZ

Gauzy Ltd. Ordinary SharesTechnology

$0.50+$0.08

+18.7%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours, so the 18.68% rally in GAUZ cannot be directly attributed to a specific public announcement or event based on available evidence.

The stock moved up sharply with no corresponding news in the Yahoo Finance RSS feed over the past two days. This does not rule out catalysts; it could indicate a press release not yet syndicated to major news outlets, a technical bounce after weakness, short covering, or general renewed interest in small-cap specialty materials companies like Gauzy (which focuses on electrochromic glass technology). Without visibility into intraday volume, institutional activity, or delayed news sources, the true driver remains unclear. The jump from such a low price point also suggests this may be a thinly traded micro-cap where modest volume can generate outsized percentage moves.

EXYN

Exyn Technologies, Inc.Technology

$3.97+$0.61

+18.1%

NASDAQ · Mkt cap $16 M

No news headlines were found in the last 48 hours for EXYN, so the 18% gain likely reflects a technical rebound, sector momentum, or undisclosed corporate development not yet picked up by major news feeds.

The absence of any news headlines in the Yahoo Finance RSS feed over the past two days means we cannot identify a specific catalyst from traditional media sources. EXYN is a small-cap robotics and autonomous systems company, and stocks in this category can experience sharp moves on thin liquidity from technical trading, short-covering, or delayed announcements that circulate via press releases or investor channels before mainstream media pickup. The stock's ranking as the 25th biggest gainer suggests sector-wide momentum or a coordinated institutional or retail accumulation event. Without access to company filings, social media chatter, or direct press releases issued today or yesterday, we cannot confirm whether an acquisition rumor, partnership, funding round, or product milestone drove the move. The timing and size of the gain (18% in one day) is material enough to suggest something beyond random walk, but identifying it requires sources beyond the provided headlines.

BHVN

Biohaven Pharmaceutical Holding Co Ltd

$16.97+$2.57

+17.8%

ILLR

Triller Group Inc.Technology

$0.98+$0.15

+17.8%

NASDAQ · Mkt cap $20 M

No news headlines were published in the last 48 hours regarding ILLR, so the 17.83% gain on August 26, 2026 cannot be attributed to a specific announced event; the move likely reflects technical trading, delayed market reaction to older news, or retail interest.

The absence of recent news headlines makes it impossible to link ILLR's strong intraday gain to a concrete catalyst. Triller Group is a social media and entertainment platform that has historically been volatile and subject to retail trading interest. For a stock trading near $1 with this volatility profile, a 17% single-day move could stem from several non-news sources: technical bounce off support, short covering, options expiration mechanics, delayed digestion of earnings or business updates released more than 48 hours prior, social media chatter, or sector rotation into digital media names. Without a headline tie-in, we cannot determine which explanation applies here.

GCDT

Green Circle Decarbonize Technology LimitedIndustrials

$0.43+$0.07

+17.8%

NYSE · Mkt cap $5.2 M

No news headlines were found in the last 48 hours, so the 17.81% gain on GCDT cannot be tied to a specific announced event; the move is likely driven by technical factors, retail trading activity, or delayed market reaction to an earlier announcement.

The absence of recent news makes it impossible to identify a definitive catalyst for GCDT's gain. Green Circle Decarbonize Technology is a small-cap decarbonization technology company trading at $0.43, a price point typical of volatile micro-cap stocks that experience outsized percentage moves on modest dollar volume. The gain could reflect short covering, momentum trading, or a delayed market reaction to news that appeared before the 48-hour window. Alternatively, if the stock has high short interest or is a Reddit/retail trading community focus, social media activity or technical breakouts can drive sharp gains independently of fundamental news. Without evidence of earnings, a partnership announcement, or regulatory action, we cannot establish the cause beyond speculation about trading mechanics.

SMXT

Solarmax Technology Inc.Technology

$3.12+$0.47

+17.5%

NASDAQ · Mkt cap $18 M

No news headlines were found in the last 48 hours, so the 17.55% gain cannot be attributed to any reported event; the jump likely stems from technical trading, delayed announcements, or market rumors not yet captured in mainstream financial feeds.

The absence of any Yahoo Finance headlines in the last 48 hours is notable given SMXT's strong 17.55% one-day rally, which ranked it among the top 29 gainers on NASDAQ. For a solar technology stock, typical catalysts would include positive earnings surprises, new contract announcements, favorable solar industry policy developments, or analyst upgrades. The lack of reported news suggests either a delay in information reaching headline feeds, a technical or short-covering event, or unconfirmed market rumors driving retail or institutional buying. Without access to news outside the stated source, alternative explanations such as broader clean energy sector momentum, insider transactions, or delayed disclosure of material information cannot be ruled out but remain speculative.

AEON

AEON Biopharma, Inc.Healthcare

$0.25+$0.04

+17.3%

NYSE · Mkt cap $9.9 M

No news headlines were found in the last 48 hours, so the 17.35% gain on AEON stock cannot be directly attributed to a reported announcement or event. The move likely reflects technical trading, speculative positioning, or an untracked news item.

The absence of recent headlines makes it difficult to pinpoint a specific catalyst for AEON's substantial single-day gain. A micro-cap biotech stock trading at $0.25 is often subject to volatile swings driven by factors including technical breakouts, short covering, retail trading activity, or small clinical trial results that may not immediately appear in major news feeds. Alternatively, the move could reflect delayed coverage of an announcement made outside the 48-hour window, internal trading activity, or sector-wide momentum in biotechnology. Without headline evidence, any explanation remains speculative rather than fact-based.

AIHS

Senmiao Technology LtdIndustrials

$1.77+$0.25

+16.4%

NASDAQ · Mkt cap $21 M

Senmiao Technology announced a name change to Valor Energy Inc. on August 26, 2026, which likely triggered the 16.45% gain as the rebranding signals a strategic pivot toward energy and potentially higher-growth sectors.

The company announced a corporate name change from Senmiao Technology Limited to Valor Energy Inc., described in the press release as repositioning itself as an emerging digital infrastructure, energy and strategically emerging industries company. The timing of the announcement on the same day as the stock's 16.45% surge suggests investors reacted positively to the rebranding narrative, which implies a shift away from what may have been a less attractive or outdated business identity toward energy sector exposure. The energy sector name carries connotations of infrastructure and growth potential. However, the headline provided is truncated and does not contain specific operational details, financial guidance, or strategic partnerships that might independently justify such a move. The magnitude of the gain (16.45%) for what is primarily a name change suggests either significant investor enthusiasm for the energy repositioning story or potential institutional buying tied to the rebranding announcement.

INTZ

Intrusion, Inc.Technology

$0.69+$0.09

+15.7%

NASDAQ · Mkt cap $14 M

No news headlines were found in the last 48 hours to explain INTZ's 15.74% jump, so the catalyst remains unknown; the move may reflect technical trading, delayed news dissemination, or market rumors.

The absence of recent news headlines creates a gap between the observed price action and identifiable catalysts. For a small-cap cybersecurity firm like Intrusion Inc., a 15% single-day gain without contemporaneous news coverage is notable. This pattern typically occurs in three scenarios: first, technical factors such as short covering or options expiration mechanics that move low-float stocks; second, delayed news that may have circulated on specialized platforms, earnings calls, or insider channels before appearing in mainstream financial feeds; and third, sector-wide momentum or thematic trading unrelated to INTZ-specific fundamentals. Without corroborating headlines, none of these hypotheses can be confirmed from the evidence at hand.

XOS

Xos, Inc.Industrials

$3.64+$0.53

+15.7%

NASDAQ · Mkt cap $41 M

Xos announced a follow-on order from Xcel Energy for three additional Xos Hub mobile fast-charging systems in Colorado, likely driving the 15.73% intraday gain as evidence of sustained commercial traction.

The headline documents a concrete follow-on order from an established utility customer, Xcel Energy, for three more Xos Hub mobile charging systems to support fleet fast-charging in Colorado. This is a repeat order rather than a first-time win, which signals customer satisfaction and recurring revenue potential. For a commercial EV infrastructure company like Xos, announced customer orders typically serve as near-term revenue visibility and proof of market adoption. The stock's strong rank as the 33 biggest gainer suggests the market interpreted this as material validation of the business model. No earnings, guidance, or broader corporate developments were reported in the provided headlines, so the move appears directly attributable to this customer win announcement.

FVNNR

Future Vision II Acquisition Corporation Right

$0.21+$0.03

+15.3%

CRWD

Crowdstrike Holdings IncTechnology

$189.42+$26.42

+14.3%

NASDAQ · Mkt cap $218 B

CrowdStrike reported Q2 earnings and revenue that beat estimates by 6.9% and 2.15% respectively, raised full-year guidance to $6.01 billion, and saw revenue grow 25.8% year-over-year to $1.47 billion, triggering the 14.31% gain.

The headlines establish a clear earnings beat narrative. CrowdStrike delivered Q2 fiscal 2027 results that exceeded both earnings per share and revenue expectations. The company posted $1.47 billion in quarterly revenue and raised its full-year outlook materially above prior guidance. Multiple sources confirm the stock jumped 9-12% in after-hours trading immediately following the announcement, with the gain extending into the regular session to reach 14.31% by market close. The cybersecurity sector appears to have had a strong earnings day overall, with Okta and Salesforce also noted as earnings winners. The combination of a beat, raised guidance, and robust year-over-year revenue growth of 25.8% explains the magnitude of the move in a growth-sensitive software stock.

CRM

salesforce.com IncTechnology

$206.11+$28.78

+14.1%

NYSE · Mkt cap $200 B

Salesforce crushed Q2 earnings expectations with an 80% EPS beat and revenue above guidance, raised full-year revenue outlook, and announced an expanded AI partnership with Anthropic called Claudeforce, triggering a 14% rally.

Salesforce reported adjusted EPS of $5.90 versus consensus expectations, representing an 80% earnings surprise, with revenue of $11.35 billion slightly exceeding the $11.32 billion estimate. The company raised full-year revenue guidance to $46.1 billion to $46.4 billion, signaling confidence in demand. CEO Marc Benioff called it one of the company's best quarters ever, citing strong AI adoption. The timing of the Claudeforce partnership announcement with Anthropic on the same day reinforces the narrative that Salesforce is capitalizing on enterprise AI demand rather than being disrupted by it, addressing a key investor concern about whether AI tools would cannibalize CRM software demand. The combination of a material earnings beat, margin expansion, guidance raise, and strategic AI positioning in a single earnings cycle provides multiple bullish catalysts for institutional buying.

NDRA

ENDRA Life Sciences IncHealthcare

$5.38+$0.67

+14.1%

NASDAQ · Mkt cap $5.7 M

No news headlines were found in the last 48 hours, so the 14.12% gain cannot be attributed to a specific announced event. The move likely reflects technical trading, delayed news, or market rumors.

ENDRA Life Sciences, a medical device company focused on minimally invasive solutions, experienced a substantial single-day gain with no corresponding news in the Yahoo Finance RSS feed over the prior 48 hours. This disconnect suggests either a delayed market reaction to older news, technical momentum or short-covering, or an event not yet captured in mainstream financial headlines. Biotech and medical device stocks of this size and profile often respond sharply to clinical trial results, regulatory clearances, partnership announcements, or insider activity. Without confirmation of any such catalyst in the provided news, the underlying driver remains speculative. It is also possible that news exists but has not yet propagated to the RSS feed checked.

SCKT

Socket Mobile IncTechnology

$0.78+$0.10

+14.1%

NASDAQ · Mkt cap $5.6 M

No news headlines from the past 48 hours were found for Socket Mobile Inc, so the 14% gain cannot be directly attributed to a specific announcement. The move may reflect technical trading, delayed news dissemination, or broader market sentiment.

Socket Mobile is a small-cap mobile data capture and connectivity solutions company, and the absence of recent headlines makes it difficult to pinpoint a definitive catalyst for today's 14% surge. Given the stock's modest price point of $0.78 and micro-cap characteristics, moves of this magnitude can result from several non-news-driven sources: technical chart breakouts or oversold bounces, short covering or retail interest, general small-cap volatility, or news that may have circulated through less-monitored channels before appearing on major finance feeds. For companies in this category, the lag between local announcement and major news aggregation can also explain gaps. Without concrete earnings, contract, or strategic announcements in the provided headlines, any explanation remains speculative rather than grounded in a specific corporate event.

IRHOR

Iron Horse Acquisitions Corp. II Rights

$0.18+$0.02

+13.7%

NASDAQ

No news headlines were found in the last 48 hours, so the 13.71% gain in IRHOR rights cannot be directly attributed to a specific announced catalyst; the move likely reflects either technical trading activity in a low-liquidity microcap or delayed market reaction to an earlier event.

Iron Horse Acquisitions Corp. II Rights are a microcap SPAC-related security, and such instruments are typically thinly traded with high volatility. The absence of any news in the past 48 hours suggests the price jump was not driven by a named company acquisition announcement, financial update, or regulatory event. However, SPAC rights can move sharply on technical factors, including short covering, rebalancing, or retail attention following news about the SPAC sponsor or prior announcement cycles. Another possibility is that news relevant to the underlying SPAC or its target company was published earlier and the market is only now pricing it in, or that trading activity in the common stock or warrants has created spillover buying pressure in the rights. Without access to headlines or trading volume context, the specific trigger remains unclear.

FLGC

Flora Growth Corp.

$5.75+$0.69

+13.6%

SHPH

Shuttle Pharmaceuticals Holdings IncHealthcare

$3.60+$0.46

+13.4%

NASDAQ · Mkt cap $2.3 M

No news headlines were found in the last 48 hours for SHPH, so the 13.37% gain likely reflects technical trading, delayed news pickup, or market sentiment shifts in small-cap biotech without confirmed catalyst.

The absence of recent news headlines makes it impossible to identify a specific catalyst for Shuttle Pharmaceuticals' sharp 13.37% single-day gain. For a small-cap pharmaceutical company, typical drivers of sudden moves include clinical trial results, regulatory decisions, partnership announcements, or insider activity. Given SHPH's clinical-stage profile and the lack of headline coverage, the jump could reflect several scenarios: a delayed market reaction to older news that has now gained attention, short-covering if the stock has notable short interest, technical buying from oversold conditions, or potentially an unannounced development not yet picked up by major news feeds. Without concrete information, pinpointing the specific cause is not possible. The move ranks the stock among the top 41 gainers, suggesting meaningful volume or institutional interest, but the absence of corroborating news limits confidence in any single explanation.

ACTU

Actuate Therapeutics, Inc.Healthcare

$1.78+$0.21

+13.3%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 13.30% gain likely stems from technical factors, delayed announcements, or market rumors specific to this micro-cap biotech stock.

Actuate Therapeutics is a small-cap biotech company, and the lack of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to attribute the move to a specific corporate event such as clinical trial results, FDA decisions, partnership announcements, or earnings. For stocks of this size and sector, price moves of this magnitude without accompanying news are frequently driven by short covering, retail momentum, options-related flows, or unconfirmed market chatter that has not yet reached major news wires. It is also possible that a material announcement was made but not yet indexed by the RSS feed used here, or that the move reflects delayed market reaction to news from before the 48-hour window. Without additional information, any specific explanation remains speculative.

CAPR

Capricor Therapeutics IncHealthcare

$9.37+$1.09

+13.2%

NASDAQ · Mkt cap $464 M

Capricor surged 13.15% after the FDA extended its deramiocel application review deadline by three months to November 22, eliminating an imminent rejection risk that had likely weighed on the stock heading into the original August 22 deadline.

The headline from August 24 establishes a concrete FDA action: the regulator extended Capricor's deramiocel review timeline from August 22 to November 22, 2026. This three-month extension is material for a small-cap biotech company dependent on a single therapeutic application because it removes the binary near-term rejection risk that would have crystallized in two days. The market interpreted the extension as a neutral-to-positive signal, as it preserves the possibility of eventual approval rather than allowing an imminent definitive rejection. HC Wainwright's simultaneous note flagging high rejection risk and maintaining a Neutral rating suggests the extension is valued more for eliminating downside timing pressure than for signaling approval confidence. The broader healthcare sector weakness noted in the second headline provides context but does not explain CAPR's outperformance, reinforcing that the FDA extension is the primary driver.

VYX

Ncr Voyix Corp

$8.87+$1.06

+13.1%

MLSS

Milestone Scientific Inc

$0.54+$0.06

+12.8%

XXII

22nd Century Group IncConsumer Defensive

$3.39+$0.38

+12.6%

NASDAQ · Mkt cap $1.4 M

No headlines were found in the last 48 hours, so the 12.62% gain cannot be attributed to a specific disclosed event. The move likely reflects either a delayed market reaction to an older announcement, technical buying, or undisclosed developments.

Despite the significant intraday gain that placed XXII at 46th among daily gainers, no relevant news headlines appeared in the Yahoo Finance RSS feed for the past two days. This disconnect suggests the catalyst either predates the 48-hour window, stems from social media or community discussion rather than official channels, or reflects technical factors such as short covering or momentum trading. XXII is a biotech-focused company that has historically been sensitive to regulatory developments, clinical trial announcements, and product adoption news. Without confirmed headlines, plausible but unverified categories include delayed positive news about reduced-nicotine cigarette regulation, licensing agreements, or shareholder sentiment shifts, but these remain speculative pending actual disclosure.

ZCMD

Zhongchao IncHealthcare

$0.81+$0.09

+12.6%

NASDAQ · Mkt cap $6.2 M

No news headlines were found in the last 48 hours for ZCMD, so the 12.62% gain likely reflects technical trading, a delayed news announcement not yet indexed, or market speculation in a low-priced micro-cap stock.

The absence of recent news headlines creates genuine ambiguity about the catalyst for today's 12.62% move in ZCMD. Stocks trading below $1 often experience volatile percentage swings on modest absolute dollar volume, and technical factors like short covering or algorithmic trading can drive sharp intraday moves without fundamental news. Additionally, news aggregation systems sometimes lag in indexing announcements, particularly for smaller exchanges or companies with limited analyst coverage. Without access to real-time market data, company filings, or social media activity, I cannot rule out a press release, SEC filing, or earnings announcement that simply has not yet appeared in the Yahoo Finance RSS feed used here. The most likely explanations fall into three categories: technical rebalancing or short squeeze activity, a delayed or not-yet-indexed company announcement, or retail/speculative trading in a penny-cap security.

GENVR

Gen Digital Inc. Contingent Value Rights

$3.94+$0.44

+12.6%

NASDAQ

No news headlines were found in the last 48 hours to explain the 12.57% jump. Given that this is a contingent value rights (CVR) security, the move likely reflects either a market repricing of the underlying Gen Digital merger terms, renewed M&A speculation, or technical trading activity.

The absence of any recent headlines is notable given the stock's strong single-day performance ranking it in the top 50 gainers. GENVR is a contingent value rights instrument tied to Gen Digital Inc., meaning its value is contingent on specific merger or operational outcomes. CVRs can experience sharp moves without accompanying news if market participants revise their probability estimates of the triggering event, if there is new merger speculation, or if technical factors (low float, short covering, or algorithmic trading) drive momentum. Without current news, the most plausible drivers are either a delayed announcement not yet indexed in the RSS feed, internal Gen Digital corporate developments that have not yet become public, or speculative positioning unrelated to fundamentals. A secondary possibility is that the move reflects broader market sentiment shift toward the underlying acquirer or sector.

AIRI

Air Industries Group

$2.61+$0.29

+12.5%

CELU

Celularity Inc.Healthcare

$0.90+$0.10

+12.5%

NASDAQ · Mkt cap $23 M

Celularity announced on August 25 that it received a Nasdaq listing compliance notification letter on August 21, likely prompting a relief rally as the market assessed the company's path forward regarding exchange compliance.

The headline reveals that Celularity received a formal notification from Nasdaq's Listing Qualifications Department regarding compliance on August 21, with the announcement made public on August 25. The text provided is truncated and does not specify the exact nature of the compliance issue or any resolution, making it impossible to determine definitively whether this was negative news, neutral news, or good news about remediation. However, the 12.49% gain suggests the market may have interpreted this as either (1) relief that the company disclosed and addressed the issue proactively, (2) evidence that remediation is underway or approved, or (3) anticipation that the listing status will be maintained. Without the full statement, it is unclear whether Celularity cured a deficiency or announced a remediation plan. This is a micro-cap stock where compliance notifications can be material but also volatile trading catalysts.

Biggest Losers

Wed, Aug 26, 2026 50

ONTX

Onconova Therapeutics IncFinancial Services

$0.60−$16.73

-96.5%

SVVC

Firsthand Technology Value Fund IncFinancial Services

$0.00−$0.01

-62.0%

NASDAQ · Mkt cap $49 K

No news headlines were found in the last 48 hours to explain SVVC's 62% decline, making the cause unclear without additional context or delayed reporting.

Firsthand Technology Value Fund Inc (SVVC) is a closed-end fund focused on venture and growth equity investments in technology companies. The 62% single-day drop with zero news coverage in the last 48 hours suggests either a delayed announcement, technical error, or market-driven revaluation of the fund's holdings. Possible causes include a sharp decline in the underlying technology stocks the fund holds, a significant portfolio write-down or impairment charge announced after market hours or through a filing rather than a press release, unexpected management changes, or liquidity issues affecting the fund's share price relative to net asset value. Without headlines or explicit reporting, the specific trigger remains speculative.

FLYX.WT

flyExclusive, Inc.

$0.10−$0.08

-44.2%

HODO

House of Doge Inc.Technology

$0.26−$0.15

-39.2%

NASDAQ · Mkt cap $33 M

No news headlines were found in the last 48 hours, so the 39% drop cannot be directly attributed to any announced event; micro-cap stocks like HODO often experience sharp moves on low volume, technical selling, or unannounced rumors.

The absence of any news in the Yahoo Finance RSS feed over the past two days means there is no documented catalyst to explain this severe decline. HODO appears to be a micro-cap or penny stock trading at $0.26, a category known for extreme volatility driven by factors other than fundamental announcements. Possible causes include technical breakdown or support level breach, sudden liquidation by a large holder, loss of retail attention or social media interest, market-wide deleveraging affecting low-liquidity names, or undisclosed negative developments that have not yet reached mainstream news feeds. Without access to order flow, insider trading filings, or real-time social sentiment, it is impossible to pinpoint the specific trigger. The stock's rank as the fourth-biggest loser suggests broad market participation in the selloff, which could indicate either coordinated selling pressure or a significant event that news services have not yet covered.

WETO

Webus International Limited Ordinary SharesTechnology

$17.50−$10.59

-37.0%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours for WETO, so the 37% single-day drop likely stems from an unannounced earnings miss, insider selling, a delayed market reaction to older news, or broad sector weakness that wasn't captured in available feeds.

The absence of any news in the last 48 hours for a stock experiencing the fifth-largest percentage decline of the day is notable and suspicious. A 37% drop of this magnitude typically requires a material catalyst: earnings disappointment, executive departures, covenant breach, delisting risk, or major contract loss. Without headline confirmation, several plausible scenarios exist. First, earnings or guidance may have been released but not yet indexed by the RSS feed. Second, the company may have issued a press release or SEC filing (8-K, prospectus amendment) that triggered selling before news aggregators picked it up. Third, a significant news event from more than 48 hours ago could have finally reached retail or algorithmic traders. Fourth, WETO could face sector-wide headwinds or a short squeeze unwind if it is thinly traded. The lack of corroborating headlines prevents narrow attribution.

DFSCW

DEFSEC Technologies Inc.Industrials

$0.02−$0.01

-33.9%

FSHPR

Flag Ship Acquisition Corporation

$0.06−$0.03

-32.7%

NASDAQ

No news headlines were found in the last 48 hours, so the 32.67% decline cannot be attributed to a specific announced catalyst. The drop likely reflects either technical selling pressure, a delayed market reaction to unreported developments, or typical volatility in a low-priced microcap security.

FSHPR is a blank-check acquisition company trading at $0.06, which places it in the microcap category where price movements are often driven by illiquidity, redemption pressure, or technical factors rather than fundamental news flow. Flag Ship Acquisition Corporation-class SPACs commonly experience sharp moves when facing shareholder redemption deadlines, failed merger negotiations, or extension votes. The absence of any news in the prior 48 hours makes it difficult to pinpoint a specific event, but such stocks are sensitive to internal corporate actions—redemption announcements, insider selling, or extension proposal voting results—that may not immediately appear in broad financial headlines. Alternatively, the decline could reflect accumulated selling pressure from a failed deal or deteriorating market sentiment toward the entire SPAC sector.

CYCU

Cycurion, Inc. Common StockTechnology

$0.46−$0.19

-29.5%

NASDAQ · Mkt cap $7.9 M

Cycurion announced a 1-for-8 reverse stock split effective August 28, 2026, which typically triggers immediate sell-offs as investors react to the dilutive perception and anticipation of the mechanical adjustment, despite the company simultaneously highlighting stronger fundamentals including imp…

The 29.46% drop coincides precisely with the announcement of a reverse stock split at an 8-to-1 ratio. While the company paired this announcement with positive operational news—gross margins reaching 29.1%, a signed $54.6M award, and improved multi-year revenue visibility—reverse stock splits are historically met with negative market reactions. Investors typically interpret reverse splits as a signal of prior weakness or dilution concerns, and the mechanical adjustment creates selling pressure as shareholders adjust positions ahead of the ex-date on August 28. The timing of positive fundamentals alongside the split announcement suggests the company may have been attempting to offset negative sentiment, but the market's immediate response indicates the structural action outweighed the operational improvements in near-term investor psychology.

NEXR

Nexera Technologies Ltd.Consumer Cyclical

$2.01−$0.70

-25.7%

IGACR

Invest Green Acquisition Corporation Rights

$0.12−$0.04

-24.9%

NASDAQ

No news was published in the last 48 hours, so the 25% intraday drop likely reflects either technical selling pressure, a delayed market reaction to older news, or sector-wide weakness in blank-check equity instruments.

IGACR is a SPAC rights offering trading at a very low price point ($0.12), which typically indicates the underlying acquisition vehicle is either near expiration, has failed to consummate a merger, or faces significant shareholder doubt about deal prospects. Rights on defunct or stalled SPACs often experience sharp declines when redemption deadlines approach or when sponsors announce extensions with dilutive terms. The absence of any headline in the last 48 hours suggests the catalyst occurred earlier or is purely technical—such as index rebalancing, options expiration, or stop-loss cascades in a thinly traded security. SPACs and their related instruments are also highly sensitive to sentiment shifts in the broader blank-check sector, which may have deteriorated without a specific story attached to this individual security.

VEEA

Veea Inc.Technology

$0.12−$0.03

-24.4%

NASDAQ · Mkt cap $8.6 M

Veea announced a 1-for-20 reverse stock split effective today, which typically signals financial distress and dilution concerns, likely triggering the 24% decline despite a positive commercial milestone announcement from the same day.

The reverse stock split announcement is the most probable driver of the sharp decline. Reverse splits are generally perceived negatively by markets because they signal that a company's stock price has fallen critically low, often indicating financial weakness or a struggle to maintain exchange listing standards. While the headline about Veea and Totalplay completing technical qualification for SecureConnect and VigiLynx offerings in Mexico appears operationally positive, it lacks revenue impact details and arrived on the same day as the reverse split announcement, which tends to dominate investor sentiment. The 1-for-20 ratio is substantial and suggests the stock had traded well below current levels prior to the split. Investors typically dump shares ahead of or immediately following reverse splits due to concerns about dilution history, cash runway, and what the split signals about management's view of the company's prospects.

SZZL

Sizzle Acquisition Corp.Financial Services

$7.99−$2.45

-23.5%

NASDAQ · Mkt cap $327 M

SZZL dropped 23.47% following news that Trasteel Holding S.A. appointed a head of investor relations in preparation for its Nasdaq listing via merger with Sizzle Acquisition Corp., suggesting deal execution risk or investor concerns about the transaction timing or structure.

The only headline provided is the appointment of Alessandro Colombi as Trasteel's head of investor relations ahead of the contemplated business combination with Sizzle Acquisition Corp. This is a procedural step that typically precedes SPAC merger closings, but the timing and tone provide limited direct explanation for a 23% single-day drop. Possible interpretations include: (a) the market had already priced in merger completion and views this as evidence of delay or uncertainty, (b) the newly created role signals the deal is still in early stages rather than imminent, or (c) the market discovered negative information about Trasteel or deal terms not reflected in this headline. Without additional context on the deal's expected closing date, valuation, or any competing news from the previous 48 hours, the headline alone does not conclusively explain the magnitude of the move.

SHOTR

RMG ML Sports Holdings Rights

$0.13−$0.04

-22.7%

NASDAQ

No news headlines were found in the last 48 hours, so the 22.71% drop in SHOTR cannot be attributed to any identifiable public announcement or event. The decline likely stems from technical selling, low liquidity, or a delayed news catalyst not yet indexed in the available feed.

SHOTR is a rights offering security tied to RMG ML Sports Holdings, a highly speculative micro-cap vehicle. The absence of any news in the last 48 hours makes it impossible to pinpoint a specific catalyst from public disclosures. However, rights offerings and shell-company-related securities are characteristically volatile and thinly traded. A 22.71% single-day drop in such a security could reflect several non-headline drivers: forced liquidation by retail investors, exaggerated price swings due to minimal float, early expiration or redemption pressure if the rights are time-sensitive, or a rumor that has not yet surfaced in major news aggregators. Micro-cap rights offerings also routinely suffer from poor sentiment as merger timelines slip or funding fails to materialize, though evidence of such news is not available here.

BPTH

Bio-Path Holdings Inc

$0.03−$0.01

-22.7%

TRUG

TruGolf, Inc.Consumer Cyclical

$0.66−$0.18

-21.6%

NASDAQ · Mkt cap $1.2 M

No news headlines appeared in the last 48 hours to explain TruGolf's 21.6% single-day drop, so the cause remains unclear without access to real-time market data or company announcements.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for this substantial intraday decline. TruGolf is a small-cap stock trading near penny-stock levels, which typically means higher volatility and sensitivity to relatively modest trading volume shifts. Possible explanations in this category include a negative company announcement not yet picked up by major news feeds, a delayed earnings miss or guidance cut, insider selling or lockup expiration, broader sector weakness in golf or entertainment technology, or technical selling pressure triggered by moving average breaks or options expiration. Without direct access to press releases, SEC filings, or real-time trading data, any specific hypothesis remains speculative.

GENB

Generate Biomedicines, Inc.Healthcare

$16.14−$4.25

-20.7%

EONR.WT

EON Resources Inc WT

$0.08−$0.02

-19.8%

GRML

Greenland Mines Ltd.Basic Materials

$5.04−$1.23

-19.5%

NASDAQ · Mkt cap $31 M

Greenland Mines announced a $20 million public offering at a 48.5% discount to the previous closing price, causing immediate shareholder dilution and triggering the 19.49% single-day decline reported as of the snapshot date.

On August 25-26, 2026, Greenland Mines announced a proposed public offering followed by pricing of $20 million in common stock at a substantial discount. One headline explicitly states the company agreed to sell four million shares at a 48.5% discount to Tuesday's closing price. This type of heavily discounted equity raise is highly dilutive to existing shareholders and typically drives sharp single-day losses as the market reprices for the increased share count and reduced ownership stakes. The announcement came alongside positive news about the Sarfartoq rare earth project valuation (up to $2.05 billion pre-tax NPV), but the negative equity dilution effect dominates initial price action in capital raises of this magnitude and discount structure. The 19.49% drop aligns with typical market reactions to substantially discounted secondary offerings.

IPST

Heritage Distilling Holding Company, Inc.Consumer Defensive

$6.00−$1.43

-19.3%

ELMD

Electromed IncHealthcare

$31.57−$7.49

-19.2%

NYSE · Mkt cap $341 M

Electromed reported record Q4 revenue and earnings that beat estimates, but the stock fell 19% after the CEO announced planned retirement, signaling leadership transition risk that overshadowed the strong financial results.

The headlines establish that Electromed delivered materially strong financial results on August 25-26: record Q4 revenue of $19.4 million (up 11.6% year-over-year), full-year EPS of $1.30 per diluted share, an earnings surprise of +21.88%, and 15 consecutive quarters of growth. By normal valuation logic, these results should support the stock price. However, the same news cycle included a CEO retirement announcement. Leadership transitions often trigger sell-offs in smaller-cap stocks due to investor concerns about execution, strategy continuity, and the quality of succession planning. The market appears to have weighted the CEO departure risk more heavily than the earnings beat, particularly given this is a $31-per-share company where CEO stability may be material to investor confidence. The 19% drop suggests meaningful concern about the transition.

DSX.WT

Diana Shipping Inc. WT

$0.49−$0.11

-18.3%

MBAI

Check-Cap Ltd.Healthcare

$6.65−$1.44

-17.8%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours to explain MBAI's 17.80% decline on August 26, 2026, so the cause remains unclear without additional information.

Check-Cap Ltd. is a medical device company focused on colorectal cancer screening technology. The stock experienced a significant single-day drop with no corresponding news in the last 48 hours according to the available headline data. In the absence of disclosed headlines, this type of move for a small-cap medical device company could plausibly result from several categories of catalyst: delayed disclosure of trial results or regulatory feedback, loss of partnership or funding, insider transactions or secondary offerings, broader sector rotation out of healthcare stocks, or technical factors such as short covering reversals. Without actual news to ground the analysis, any specific explanation would be speculative. The company's small-cap status and specialized focus make it more susceptible to outsized single-day moves on limited volume or news that may not immediately appear in major RSS feeds.

AMCI

AMCI Acquisition CorpTechnology

$4.01−$0.85

-17.5%

NASDAQ · Mkt cap $115 M

No news headlines were found in the last 48 hours to explain AMCI's 17.49% decline, making the specific trigger unknown, though SPACs often face pressure from redemptions, deal uncertainty, or broader market moves.

The absence of recent news headlines is notable given the severity of the drop. AMCI is a SPAC (special purpose acquisition company), a class of security particularly sensitive to redemption pressure, deal announcement delays, valuation concerns, or shifts in merger agreement terms. Without specific news to anchor the decline, the move could reflect several typical SPAC catalysts: mounting redemption requests ahead of a shareholder vote, unexpected deal complications, expiration of a regulatory timeline, or general sector rotation away from blank-check equities. It is also possible the decline reflects older news not captured in the 48-hour window, technical selling, or broader market weakness on that date. The rank as the 23rd biggest loser suggests sector-wide or SPAC-specific pressure rather than an isolated company-specific event, though this remains inference without corroborating headlines.

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.01−$0.00

-17.4%

NASDAQ

No news headlines were found in the last 48 hours to explain the 17.45% drop in BNCWW warrant shares. The decline likely reflects either technical liquidation, expiration-driven volatility, or broader sentiment shifts affecting warrants with minimal liquidity.

No recent news was available to identify a specific catalyst for the decline. BNCWW is a warrant issued by CEA Industries, a class of security that tends to be highly sensitive to time decay, implied volatility changes, and shifts in the underlying stock's price momentum. Warrants, especially those trading at $0.01, are prone to wide percentage swings on small absolute price movements and typically suffer from extremely low trading volume and wide bid-ask spreads. The sharp single-day loss could stem from several sources: expiration concerns if the warrant's life is shortening, a decline in the underlying stock that cascades more sharply into warrant pricing, forced liquidations by holders, or simply a repricing correction driven by technical factors rather than fundamentals. Without news, structural triggers like dividend unwinds or index rebalancing are also possible but less likely to explain a 17.45% drop in a single day.

GCL

GCL Global Holdings Ltd Ordinary SharesCommunication Services

$0.60−$0.12

-16.9%

NASDAQ · Mkt cap $74 M

GCL dropped 16.91% on August 26, but the two recent headlines describe positive news about its gaming publishing subsidiary 4Divinity showcasing titles at gamescom 2026, suggesting the sell-off was likely driven by a separate market factor or sector headwind unrelated to the published announcements.

The two news items from the past 48 hours both report positive developments: 4Divinity's games featured prominently at gamescom 2026 opening night and the company secured a premier sponsorship from ADATA. These are typically viewed as positive marketing and visibility events for a gaming publisher. However, the 16.91% single-day decline contradicts what would normally be expected from such announcements. This disconnect suggests either an unannounced catalyst not captured in the headlines provided, a broader sector decline affecting gaming stocks, or deteriorating investor sentiment toward GCL independent of these gamescom announcements. The timing of the positive news release after market hours on August 26 rules out investor reaction to that specific announcement as the primary driver of the intraday sell-off.

TONT.WT

Graf Global Corp.

$0.40−$0.08

-16.7%

BVC

BitVentures LimitedTechnology

$12.13−$2.38

-16.4%

NASDAQ · Mkt cap $2.4 B

No news headlines were published in the last 48 hours for BVC, so the 16.37% decline cannot be attributed to a specific announced event. The drop likely stems from technical selling, market-wide pressure, or undisclosed news not yet indexed.

The absence of any news headlines in the Yahoo Finance feed over the past two days makes it impossible to pinpoint a concrete catalyst for BVC's sharp 16.37% decline. For a company like BitVentures Limited, which appears to operate in the cryptocurrency or blockchain investment space based on its name, typical drivers of large single-day drops include: adverse moves in underlying crypto assets or sentiment, margin call cascades among leveraged positions, sector-wide regulatory concerns, insider selling signals, or delayed disclosure of unfavorable financial results or guidance. Without access to intraday market commentary, social media mentions, or company filings posted outside the RSS feed, we cannot distinguish between these possibilities. The stock's ranking as the 27th largest loser suggests the move was significant enough to be visible market-wide but does not indicate whether it was driven by micro-cap volatility or macro headwinds.

AKAN

Akanda Corp.Healthcare

$4.21−$0.77

-15.4%

NASDAQ · Mkt cap $2.6 M

No news headlines were found in the last 48 hours, so the 15.38% drop cannot be directly attributed to a specific announced event. The decline likely stems from sector headwinds, technical selling, or unreported developments in the cannabis or pharmaceutical space where Akanda operates.

Akanda Corp. is a cannabis and specialty pharmaceutical company, and its stock dropped 15.38% on a day when no material news appeared in the major financial feeds. This disconnect between price action and reported news is common for smaller-cap cannabis stocks, which can experience sharp moves due to several factors not always immediately captured in headline aggregators. Possible causes include sector-wide pressure (regulatory concerns, tax policy shifts, or broader cannabis market weakness), technical selling triggered by a broken support level or options expiration, short-seller activity, or an announcement that appeared on the company's investor relations page or in a press release but has not yet propagated to Yahoo Finance's RSS feed. Without confirmed news, we cannot establish causation, only that something moved the market's view of the stock meaningfully during the session.

MEDS

Trxade Group IncHealthcare

$1.33−$0.21

-15.3%

NASDAQ · Mkt cap $4.4 M

No news headlines were found in the last 48 hours for MEDS, so the 15.26% drop cannot be attributed to a specific disclosed event. The decline may reflect broader market weakness, technical selling, or undisclosed developments.

The absence of recent news makes it difficult to pinpoint a direct catalyst for the 15.26% decline in MEDS on August 26, 2026. Trxade Group is a small-cap pharmaceutical distribution and tech platform, and stocks in this category can be sensitive to several factors even without headline-driven catalysts: sector-wide pressure on generic drug pricing or pharmaceutical distributors, technical selling or stop-loss cascades given the stock's low price point around $1.33, changes in analyst ratings not yet reflected in major news feeds, short-term liquidity dynamics, or broader market risk-off sentiment. Without access to news sources beyond the Yahoo Finance RSS provided, it is also possible that material information was disclosed through other channels or that a delay exists in news aggregation.

GOSS

Gossamer Bio IncHealthcare

$0.17−$0.03

-15.2%

NASDAQ · Mkt cap $77 M

No news headlines were found in the last 48 hours, so the 15.25% drop in GOSS stock cannot be attributed to any publicly announced event or announcement during this period.

The absence of recent news headlines makes it impossible to identify a specific catalyst for today's decline. Gossamer Bio is a clinical-stage biopharmaceutical company, and stocks in this category typically respond sharply to clinical trial results, FDA decisions, financing announcements, or changes in management or strategic direction. Given the magnitude of the drop and the lack of public news, the decline could reflect several possibilities: a delayed market reaction to an older announcement, a negative pre-market rumor or social media signal, technical selling pressure, or a broader sector rotation away from unprofitable biotech companies. Without access to company filings, conference calls, or contemporaneous market commentary, it is not possible to determine which category of cause is most likely.

AIEV

Thunder Power Holdings, Inc.Consumer Cyclical

$0.12−$0.02

-15.0%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours to explain AIEV's 15% decline, so the cause remains unclear; the drop may stem from technical selling, broader sector weakness, or undisclosed company developments.

Thunder Power Holdings (AIEV) fell 15% on August 26 with no headlines published in the prior 48 hours according to the provided RSS feed. This absence of contemporaneous news makes direct causal attribution impossible. AIEV is a micro-cap stock trading at $0.12, which typically exhibits high volatility and thin liquidity. Stocks in this category often move sharply on technical factors such as stop-loss cascades, options expiration dynamics, or momentum reversals, particularly when trading volume spikes. Alternatively, the decline could reflect delayed market reaction to an earlier announcement, sector-wide headwinds in electric vehicle or automotive stocks, or private information not yet reflected in public headlines. Without access to intraday volume data, insider activity, or broader market context for that trading day, pinpointing the precise trigger is not feasible.

GIPR

Generation Income Properties Inc.Real Estate

$0.46−$0.08

-14.8%

NASDAQ · Mkt cap $253 K

Generation Income Properties sold non-core assets and is using the proceeds to redeem preferred equity, a sign of financial stress that typically signals weakness to equity investors and likely triggered the 14.79% drop.

The headline indicates that GIPR is aggressively reducing debt through asset sales and preferred equity redemption, directing approximately $4.04 million toward Loci Capital preferred equity paydown. While debt reduction is nominally constructive, the mechanics here suggest financial pressure: the company is forced to divest non-core properties to meet obligations, which can signal either weakening cash flow or deteriorating asset quality. For a micro-cap income property company trading at $0.46, such moves often concern equity holders because they suggest management is prioritizing creditor claims over shareholder value creation. The market may be interpreting this as evidence that core operations are insufficient to service debt naturally, making equity a riskier claim on future cash flows. This is a common pattern for distressed REITs and special situation stocks.

FBDT

First Breach Inc.

$1.22−$0.21

-14.7%

TEAD

Teads B.V.Communication Services

$0.47−$0.08

-14.6%

NASDAQ · Mkt cap $61 M

No news headlines were found in the last 48 hours, so the 14.63% drop cannot be directly attributed to a specific announced event. The decline likely reflects either technical selling, broader market weakness, or undisclosed developments.

The absence of any recent news headlines makes it impossible to pinpoint a definitive catalyst for TEAD's sharp 14.63% decline to $0.47. At this price level and given the stock's rank as the 34th biggest loser of the day, the move appears significant relative to broader market activity. For a stock trading near penny-stock territory, typical drivers of sharp declines without corresponding news coverage include technical selling pressure following a prior rally, margin calls or forced liquidations, deterioration in market sentiment toward the sector or company type, or delayed disclosure of negative developments. Without access to intraday trading data, SEC filings, or contemporaneous news from other sources, we cannot distinguish between these possibilities. The stock's position as a top loser suggests it underperformed significantly compared to the overall market on this date.

EMAT

Evolution Metals & Technologies Corp.Basic Materials

$3.35−$0.56

-14.3%

NASDAQ · Mkt cap $2.0 B

EMAT dropped 14.31% with no news reported in the last 48 hours, so the cause remains unclear; possible drivers include technical selling, sector headwinds, or unreported company developments.

No headlines appeared in the Yahoo Finance RSS feed over the last 48 hours to explain EMAT's sharp 14.31% decline. This absence of news is notable for a stock that ranks 35th among daily losers, suggesting either the sell-off preceded major news distribution or was driven by factors outside traditional newswire coverage. For a company like Evolution Metals & Technologies, typical catalysts would include missed earnings or guidance cuts, changes in commodity or technology sector valuations, insider selling, analyst downgrades, or negative developments in their specific markets. Without confirmed reporting, attribution remains speculative. The drop is material enough to warrant investigation into company filings, earnings calendars, or sector-specific events that may not yet be reflected in mainstream headlines.

SMTK

SmartKem, Inc.Technology

$4.21−$0.66

-14.2%

NASDAQ · Mkt cap $2.2 M

SmartKem shares fell 14% despite positive premarket momentum and a bullish partnership announcement, suggesting the rally exhausted and profit-taking followed the spike, or market sentiment shifted midday independent of the news.

The headlines present a confusing picture. The first item describes a premarket surge of 24% driven by speculative buying, yet the stock closed down 14% on the day. The second headline announces a favorable acceleration of the Tivani Project by partner Ferrox with earlier-than-expected production timelines, which would normally support a continued rally. This pattern suggests either that the initial premarket spike triggered automated profit-taking once the stock opened regular hours, or that the positive news release itself was interpreted as insufficient to justify the earlier speculative run-up. It's also possible broader market conditions or sector headwinds overwhelmed any benefit from the partnership announcement. Without knowing the intraday timeline precisely or seeing any commentary on valuation concerns, we cannot definitively establish which mechanism drove the reversal.

NUR

Nuran Wireless Inc.

$1.71−$0.31

-14.1%

SKIL

Skillsoft Corp.Consumer Defensive

$6.77−$1.11

-14.0%

NYSE · Mkt cap $71 M

No news headlines were available in the 48 hours preceding the 14.03% drop, making it impossible to identify a specific catalyst for Skillsoft's decline from available public information.

Skillsoft experienced a significant one-day loss ranking it among the top 38 losers on the exchange, yet no relevant news items appeared in the Yahoo Finance RSS feed during the relevant timeframe. This disconnect suggests either a delayed reporting lag, an after-hours or pre-market announcement not yet captured in the RSS feed, or a market reaction to broader sector headwinds or technical factors. For a software training and enterprise learning company like Skillsoft, typical catalysts would include earnings misses or guidance cuts, loss of major contracts, competitive pressures, executive departures, or macroeconomic shifts affecting corporate training budgets. The absence of any headline attribution makes it difficult to distinguish between company-specific and market-wide factors driving the decline.

SUPX

Super X AI Technology LimitedTechnology

$9.39−$1.48

-13.8%

NASDAQ · Mkt cap $283 M

SuperX announced a major $38.8 million Nvidia B300 server order from a Japanese customer on August 25, yet the stock fell 13.77% the next day, suggesting market skepticism about deal value, execution risk, or profit margins despite the headline-positive news.

The timing is counterintuitive. SuperX released two nearly identical announcements on August 25 describing receipt of a $38.8 million purchase order from Woodman Inc. for Nvidia B300 servers through its Japanese subsidiary. This should ordinarily be equity-positive news—a concrete, named customer contract worth nine figures accelerates revenue visibility and validates the company's position in Japan's AI infrastructure buildout. However, the stock dropped sharply the following trading day. Possible explanations: investors may have viewed the deal size or margin structure as disappointing relative to prior expectations, questioned execution risk or payment terms, interpreted the announcement as late or already priced in, or reacted to a broader market pullback in AI hardware infrastructure stocks. Without additional earnings data, guidance, or competitive context, we cannot determine whether the decline reflects fundamental disappointment in the deal itself or exogenous market factors.

BPACR

Blueport Acquisition Ltd Rights

$0.13−$0.02

-13.4%

NASDAQ

No news headlines were found in the last 48 hours, but BPACR is a rights offering security tied to a SPAC, which typically trades on acquisition developments, redemption activity, or shifts in sponsor/target sentiment rather than company fundamentals.

The absence of recent news makes attribution difficult, but BPACR's structure as a rights offering for a blank-check acquisition vehicle means its price is primarily sensitive to changes in the probability or terms of a transaction closing, sponsor reputation, or redemption levels. Rights offerings often trade at thin margins and with high volatility when underlying SPAC sentiment shifts. The 13.4% single-day drop could reflect negative commentary about Blueport's acquisition target or sponsor, increased redemption expectations, or a broader pullback in SPAC enthusiasm. It could also represent technical selling in a low-float security. Without named catalyst headlines, the most likely drivers are either transaction-specific news not yet captured in search results, sentiment shifts among institutional holders, or general market deleveraging in speculative SPAC-related securities.

NVA.WT

$7.30−$1.10

-13.1%

DDC

DDC Enterprise LimitedConsumer Defensive

$0.59−$0.09

-13.0%

NYSE · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 13% decline cannot be attributed to a specific announced event. The drop likely stems from technical selling, market sentiment, or undisclosed developments.

DDC Enterprise Limited experienced a sharp 13% single-day decline with zero corroborating news in the prior 48 hours. This disconnect between price action and reported headlines suggests either the catalyst was not yet picked up by major news feeds, occurred via non-traditional channels, or the move was driven by technical factors such as option expiration, margin call liquidation, or broad sector weakness. For a lower-priced stock trading at $0.59, moves of this magnitude can also reflect thin trading volume and outsized reactions to ordinary market dynamics. Without headline evidence, the most probable categories would be intraday technical breakdown, delayed dissemination of company-specific news, or macro/sector headwinds affecting the broader market.

MODD

Modular Medical, Inc.Healthcare

$3.29−$0.49

-13.0%

NASDAQ · Mkt cap $13 M

No news headlines were available in the last 48 hours, so the 13% drop cannot be directly attributed to a company-specific announcement. The decline likely reflects broader market conditions, technical selling, or delayed reaction to an earlier event not captured in the provided headlines.

The absence of recent news makes it difficult to pinpoint a specific catalyst for Modular Medical's 12.96% single-day decline. For a small-cap medical device or modular medical equipment company, typical drivers of sharp downward moves include negative clinical trial results, FDA warning letters or clearance delays, earnings misses, guidance cuts, loss of a major customer or contract, competitive threats, or analyst downgrades. Without headlines in the snapshot window, the move could also reflect profit-taking after a recent run-up, sector-wide weakness in medical stocks, or a delayed market reaction to news released earlier. Technical factors such as low liquidity and stop-loss cascades are also plausible for smaller NASDAQ names. The rank of number 43 biggest loser suggests this was a notably weak day for the stock relative to the broader market.

FGL

Founder Group Limited Ordinary SharesIndustrials

$0.19−$0.03

-12.9%

NASDAQ · Mkt cap $475 K

Founder Group announced a 19.90% stake acquisition in Malaysian EV charging operator Nichcom Go on August 25-26, but the market responded with a 12.93% sell-off, suggesting investor skepticism about the strategic value or capital deployment of this investment.

The company disclosed two related announcements within 48 hours regarding its investment in Nichcom Go, an operator of the SpacePlus EV charging network in Malaysia. The headlines frame this as a strategic expansion into the EV charging market and a potential synergy vehicle for the company's solar and battery storage capabilities. However, the sharply negative price action on the day of announcement indicates the market did not view this favorably. Possible explanations for the sell-off include concerns about capital allocation efficiency, doubts about the viability or profitability of the Malaysian EV charging market, dilution concerns if the stake was funded via equity issuance, or general skepticism about whether an EPCC solar provider can execute successfully in adjacent EV charging infrastructure. Without detail on deal structure, valuation, or funding source, the precise trigger cannot be determined from the headlines alone.

SYRE

Spyre Therapeutics, Inc.

$93.61−$13.82

-12.9%

SBEV

Splash Beverage Group, Inc.Consumer Defensive

$0.37−$0.05

-12.7%

NYSE · Mkt cap $2.5 M

Splash Beverage (now Endovia Health Sciences) announced a positive FDA milestone for its veterinary oncology program on Aug 25, yet the stock fell 12.72% the next day, suggesting market skepticism about the clinical or commercial viability of the CannEpil program or broader concerns about the com…

The company achieved an FDA Investigational New Animal Drug filing for its companion-animal oncology program CannEpil, which represents genuine regulatory progress. However, the stock declined sharply the following trading session despite ostensibly positive news. This disconnect suggests several possibilities: (1) investors may view early-stage veterinary oncology as a high-risk, low-probability commercial opportunity relative to the company's prior beverage business; (2) the market may be skeptical about the company's ability to execute in a new therapeutic area; (3) existing shareholders may have anticipated this milestone and used it as a selling opportunity; or (4) the announcement revealed details that concerned the market regarding trial design, timeline, or competitive positioning. Without broader context on analyst sentiment, institutional ownership, or competing news, the exact reason for the sell-off cannot be determined with certainty from the headline alone.

CNFR

Conifer Holdings IncFinancial Services

$6.33−$0.92

-12.7%

NASDAQ · Mkt cap $89 M

No news headlines were found in the last 48 hours, so the 12.69% decline cannot be attributed to a specific announced event. The drop likely stems from technical selling, a delayed news release, or sector-wide pressure.

Conifer Holdings declined sharply on August 26 with no corresponding news in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect between price action and available headlines creates genuine uncertainty about causation. Possible explanations include a news announcement that has not yet been widely indexed or syndicated, technical or momentum-driven selling in response to earlier negative catalysts, sector headwinds affecting insurance or financial stocks broadly, options expiration effects, or internal company developments that have not yet reached major news outlets. Without access to real-time trading data or company filings released on August 26 itself, identifying the specific driver is not possible from the evidence at hand.

OMH

Ohmyhome Limited - Ordinary SharesReal Estate

$0.09−$0.01

-12.5%

NASDAQ · Mkt cap $7.7 M

No news headlines were reported in the last 48 hours for OMH, so the 12.54% decline cannot be attributed to a specific disclosed event. The drop likely reflects technical selling, broad market weakness, or undisclosed company developments.

Ohmyhome Limited experienced a notable 12.54% single-day loss with no corresponding news coverage in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect between price action and reported headlines makes causal inference challenging. For a micro-cap stock trading at $0.09, typical catalysts include dilutive financing announcements, insider selling, sector rotation out of Asian real estate tech, or momentum-driven technical breaks of support levels. Without concrete news, the decline may reflect selling pressure from a specific investor, deteriorating market conditions for the company's underlying real estate or fintech segments, or simply the high volatility characteristic of penny stocks. Delayed news disclosure to financial aggregators is also possible but cannot be confirmed here.

RFAI

RF Acquisition Corp II Ordinary SharesFinancial Services

$47.00−$6.65

-12.4%

NASDAQ · Mkt cap $93 M

No news headlines were found in the last 48 hours, so the 12.4% drop cannot be attributed to a specific disclosed event; the cause likely involves technical selling, market-wide volatility, or undisclosed developments in the SPAC's merger or business prospects.

RF Acquisition Corp II is a SPAC (special purpose acquisition company), a security type particularly sensitive to shifts in sentiment around deal timing, deal terms, or regulatory changes affecting the target company or SPAC structure itself. The absence of any headline in the past 48 hours despite a sharp 12.4% decline suggests either a delayed or off-exchange disclosure, a shift in market expectations not yet captured in public headlines, or a technical/liquidity event. SPACs are also vulnerable to redemption announcements, merger extension votes, or changes in interest rate expectations that affect blank-check company valuations. Without concrete news, the drop could reflect profit-taking, rotation out of SPAC positions, or a negative catalyst that has not yet surfaced in major financial media.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$1.00−$0.14

-12.3%

NASDAQ · Mkt cap $6.9 M

SU Group announced a $2.4 million follow-on contract award expanding its smart-hospital project, yet the stock fell 12.28%, suggesting the market viewed the news as insufficient or disappointing relative to expectations or current valuation.

The headline reports a positive development: a follow-on award that grows the total smart-hospital project contract to $13.7 million. This is concrete revenue news that would normally be expected to support or lift a stock price. However, the stock declined sharply on the same day the announcement was released, which is counterintuitive. The disconnect suggests several possibilities: investors may have perceived the contract size as smaller than anticipated, the stock may already have been priced for this deal, or there may be broader sector weakness or negative sentiment toward small-cap security services companies that overrode the positive contract news. Without additional context on prior guidance or analyst expectations, it is difficult to determine whether the award was viewed as a miss, a failure to surprise, or simply immaterial relative to the company's valuation.